5638 Federal Register / Vol. 62, No. 25 / Thursday, February 6, 1997 / Notices

outcome indicators, rather than on

intermediate measures such as process

or outputs. A project lacking a complete

and well-conceived evaluation protocol

as part of the planned activities may not

be funded.

Project Review and Funding

Within the limit of funds determined

by the Secretary to be available for the

activities described in this

announcement, the Secretary will

review applications for funds under the

specific project categories in the

FUNDING CATEGORIES section above

as competing applications and may

award Federal funding for projects

which will, in her judgment, best

promote the purpose of title V of the

Social Security Act; best address

achievement of Healthy Children 2000

objectives related to maternal, infant,

child and adolescent health and service

systems for children at risk of chronic

and disabling conditions; and otherwise

best promote improvements in maternal

and child health.

Criteria for Review

The criteria which follow are used, as

pertinent, to review and evaluate

applications for awards under all

SPRANS grants and cooperative

agreement project categories announced

in this notice. Further guidance

regarding review criteria is supplied in

application materials, which specify

final criteria.

—The quality of the project plan or

methodology.

—The need for the research or training.

—The extent to which the project will

contribute to the advancement of

maternal and child health and/or

improvement of the health of children

with special health care needs;

—The extent to which the project is

responsive to policy concerns

applicable to MCH grants and to

program objectives, requirements,

priorities and/or review criteria for

specific project categories, as

published in program announcements

or guidance materials.

—The extent to which the estimated

cost to the Government of the project

is reasonable, considering the

anticipated results.

—The extent to which the project

personnel are well qualified by

training and/or experience for their

roles in the project and the applicant

organization has adequate facilities

and personnel.

—The extent to which, insofar as

practicable, the proposed activities, if

well executed, are capable of attaining

project objectives.

—The adherence of the project’s

evaluation plans to the requirements

in the EVALUATION PROTOCOL.

—The extent to which the project will

be integrated with the administration

of the Maternal and Child Health

Services block grants, State primary

care plans, public health, and

prevention programs, and other

related programs in the respective

State(s).

—The extent to which the application is

responsive to the special concerns

and program priorities specified in

this notice.

Funding of Approved Applications

Final funding decisions for SPRANS

research and training grants are the

responsibility of the Director, MCHB. In

considering scores for the ranking of

approved applications for funding,

preferences may be exercised for groups

of applications, e.g., competing

continuations may be funded ahead of

new projects. Within any category of

approved projects, the score of an

individual project may be favorably

adjusted if the project addresses specific

priorities identified in this notice. In

addition, special consideration in

assigning scores may be given by

reviewers to individual applications

that address areas identified in this

notice as special concerns.

Public Health System Reporting

Requirements

This program is subject to the Public

Health System Reporting Requirements

(approved under OMB No. 0937–0195).

Under these requirements, the

community-based nongovernmental

applicant must prepare and submit a

Public Health System Impact Statement

(PHSIS). The PHSIS is intended to

provide information to State and local

health officials to keep them apprised of

proposed health services grant

applications submitted by communitybased nongovernmental organizations

within their jurisdictions. Communitybased nongovernmental applicants are

required to submit the following

information to the head of the

appropriate State and local health

agencies in the area(s) to be impacted no

later than the Federal application

receipt due date:

(a) A copy of the face page of the

application (SF 525).

(b) A summary of the project (PHSIS),

not to exceed one page, which provides:

(1) A description of the population to

be served.

(2) A summary of the services to be

provided.

(3) A description of the coordination

planned with the appropriate State and

local health agencies.

Executive Order 12372

The MCH Federal set-aside program

has been determined to be a program

which is not subject to the provisions of

Executive Order 12372 concerning

intergovernmental review of Federal

programs.

The OMB Catalog of Federal Domestic

Assistance number is 93.110.

Dated: January 31, 1997.

Ciro V. Sumaya,

Administrator.

[FR Doc. 97–3013 Filed 2–5–97; 8:45 am]

BILLING CODE 4160–15–P

National Institutes of Health

Submission for OMB Review;

Comment Request; ‘‘Infant Sleep

Position and Sudden Infant Death

Syndrome (SIDS) Risk’’ Study

SUMMARY: Under the provisions of

Section 3506(c)(2)(A) of the Paperwork

Reduction Act of 1995, the National

Institute of Child Health and Human

Development (NICHD), the National

Institutes of Health (NIH), has submitted

to the Office of Management and Budget

(OMB) a request to review and approve

the information collection listed below.

This proposed information was

previously published in the Federal

Register on January 29, 1996, page 2836

and allowed 60 days for public

comment. No public comments were

received. The purpose of this notice is

to allow an additional 30 days for public

comment. The NIH may not conduct or

sponsor, and the respondent is not

required to respond to, an information

collection that has been extended,

revised, or implemented on or after

October 1, 1995, unless it displays a

currently valid OMB control number.

Proposed Collection

Title: ‘‘Infant Sleep Position and

Sudden Infant Death Syndrome (SIDS)

Risk’’ Study. Type of Information

Collection Request: New. Need and Use

of Information Collection: This study is

a population-based case-control study of

infant sleeping position in relation to

the risk of SIDS to be conducted in 11

counties of California. The primary

objectives of the study are to 1)

determine the risk of SIDS associated

with sleeping in the prone or side

positions relative to the supine position;

2) identify any factors that exacerbate

the association of sleeping position with

the risk of SIDS; and 3) to establish

baseline information on the prevalence
Federal Register / Vol. 62, No. 25 / Thursday, February 6, 1997 / Notices 5639

of each sleeping position among infants

in the defined Northern and Southern

California regions. Frequency of

Response: Once. Affected Public:

Individuals. Type of Respondents:

Parents. The annual reporting burden is

as follows: Estimated Number of

Respondents: 1,350; Estimated Number

of Responses per Respondent: 1;

Average Burden Hours Per Response: 1

and Estimated Total Annual Burden

Hours Requested: 1,350. The annualized

cost for respondents is estimated at:

$13,500. There are no Capital Costs to

report. There are no Operating or

Maintenance Costs to report.

Request for Comments

Written comments and/or suggestions

from the public and affected agencies

are invited on one or more of the

following points: (1) Whether the

proposed collection of information is

necessary for the proper performance of

the function of the agency, including

whether the information will have

practical utility; (2) The accuracy of the

agency’s estimate of the burden of the

proposed collection of information,

including the validity of the

methodology and assumptions used; (3)

Ways to enhance the quality, utility, and

clarity of the information to be

collected; and (4) ways to minimize the

burden of the collection of information

on those who are to respond, including

the use of appropriate automated,

electronic, mechanical, or other

technological collection techniques or

other forms of information technology.

Direct Comments to OMB

Written comments and/or suggestions

regarding the item(s) contained in this

notice, especially regarding the

estimated public burden and associated

response time, should be directed to the:

Office of Management and Budget,

Office of Regulatory Affairs, New

Executive Office Building, Room 10235,

Washington, D.C. 20503, Attention:

Desk Officer for NIH. To request more

information on the proposed project or

to obtain a copy of the data collection

plans and instruments, contact: Dr.

Marian Willinger, Pregnancy and

Perinatology Branch, Center for

Research for Mothers and Children,

NICHD, NIH, Building 6100, Room

4B11H, 6100 Executive Boulevard,

Bethesda, MD 20852, or call non-tollfree number (301) 496–5575.

Comments Due Date

Comments regarding this information

collection are best assured of having

their full effect if received on or before

March 10, 1997.

Dated: January 29, 1997.

Benjamin E. Fulton,

Executive Officer, NICHD.

[FR Doc. 97–2883 Filed 2–5–97; 8:45 am]

BILLING CODE 4140–01–M

National Cancer Institute; Notice of

Closed Meeting

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

National Cancer Institute Special

Emphasis Panel (SEP) meeting:

Name of SEP: Small Grants Program—

Cancer Epidemiology.

Date: February 18, 1997.

Time: 1:00 p.m.

Place: Teleconference, Executive Plaza

North, Room 635B, 6130 Executive

Boulevard, Bethesda, MD 20892.

Contact Person: John W. Abrell, Ph.D.,

Scientific Review Administrator, National

Cancer Institute, NIH, Executive Plaza North,

Room 635B, 6130 Executive Boulevard, MSC

7405, Bethesda, MD 20892–7405, Telephone:

301/496–9767.

Purpose/Agenda: To evaluate and review

grant applications.

This notice is being published less than 15

days prior to the meeting due to the urgent

need to meet timing limitations imposed by

the review and funding cycle.

The meeting will be closed in accordance

with the provisions set forth in secs.

552b(c)(4) and 552b(c)(6), Title 5, U.S.C.

Applications and the discussions could

reveal confidential trade secrets or

commercial property such a patentable

material and personal information

concerning individuals associated with the

applications, the disclosure of which would

constitute a clearly unwarranted invasion of

personal privacy.

(Catalog of Federal Domestic Assistance

Program Numbers: 93.393, Cancer Cause and

Prevention Research; 93.394, Cancer

Detection and Diagnosis Research; 93.395,

Cancer Treatment Research; 93.396, Cancer

Biology Research; 93.397, Cancer Centers

Support; 93.398, Cancer Research Manpower;

93.399, Cancer Control)

Dated: January 30, 1997.

Paula N. Hayes,

Acting Committee Management Officer, NIH.

[FR Doc. 97–2884 Filed 2–5–97; 8:45 am]

BILLING CODE 4140–01–M

National Institute of Child Health and

Human Development; Notice of Closed

Meeting

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

National Institute of Child Health and

Human Development Special Emphasis

Panel (SEP) meeting:

Purpose/Agenda: To review individual

contract proposal.

Name of SEP: Production of cDNA From

Temporal and Spatial Embryonic Tissues

(Telephone Conference Call).

Date: February 28, 1997.

Time: 12:00 p.m.–1:00 p.m.

Place: 6100 Executive Boulevard, 6100

Building, Room 5E01F, Rockville, Maryland

20582.

Contact Person: Hameed Khan, Ph.D.,

Scientific Review Administrator, NICHD,

6100 Executive Boulevard, 6100 Building,

Room 5E01, Rockville, Maryland 20582,

Telephone: 301–496–1485.

The meeting will be closed in accordance

with the provisions set forth in secs.

552b(c)(4) and 552b(c)(6), Title 5, U.S.C. The

discussions of this proposal could reveal

confidential trade secrets or commercial

property such as patentable material and

personal information concerning individuals

associated with the proposal, the disclosure

of which would constitute a clearly

unwarranted invasion of personal privacy.

(Catalog of Federal Domestic Assistance

Program No. 93.864, Population Research

and No. 93.865, Research for Mothers and

Children, National Institutes of Health)

Dated: January 31, 1997.

Paula N. Hayes,

Acting Committee Management Officer, NIH.

[FR Doc. 97–2885 Filed 2–5–97; 8:45 am]

BILLING CODE 4140–01–M

National Institute of Neurological

Disorders and Stroke, Division of

Extramural Activities; Notice of Closed

Meeting

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

Name of Committee: National Institute of

Neurological Disorders and Stroke Special

Emphasis Panel (Telephone Conference Call).

Date: February 19, 1997.

Time: 1:00 p.m.

Place: National Institutes of Health, 7550

Wisconsin Avenue, Room 9C10, Bethesda,

Maryland 20892.

Contact Person: Dr. Howard Weinstein/Mr.

Phillip Wiethorn, Scientific Review

Administrator, National Institutes of Health,

7550 Wisconsin Avenue, Room 9C10,

Bethesda, MD 20892, (301) 496–9223.

Purpose/Agenda: To review and evaluate

two SBIR Phase I Topic 025 Contract

Proposals.

The meeting will be closed in accordance

with the provisions set forth in secs.

552b(c)(4) and 552b(c)(6), Title 5, U.S.C.

Applications and/or proposals and the

discussions could reveal confidential trade

secrets or commercial property such as

patentable material and personal information

concerning individuals associated with the

applications and/or proposals, the disclosure

of which would constitute a clearly

unwarranted invasion of personal privacy.